Docetaxel, cisplatin and 5-fluorouracil adjuvant chemotherapy following three-field lymph node dissection for stage II/III N1, 2 esophageal cancer.
暂无分享,去创建一个
Y. Kajiyama | N. Tomita | M. Tsurumaru | T. Hashimoto | Y. Iwanuma | T. Amano | F. Isayama | K. Ouchi | N. Sakai | T. Hashiguchi | Motomi Nasu | T. Kuniyasu | H. Inoue